pylori:Helicobacter pylori. All samples were snap-frozen in liquid nitrogen and stored in a deep freezer (-80C) until used. gastritis, were further investigated. Their expressions were validated by Western blotting and RT-PCR in 12 cases of varioliform gastritis which was matched with normal mucosa. The expression level of PEBP1 in varioliform gastritis was significantly lower (P< 0.05) while that of TXNDC5 was significantly higher than that in matched normal gastric mucosa (P< 0.05). CONCLUSION: There are some changes of protein expression in varioliform gastritis. Downregulation of PEBP1 and upregulation of TXNDC5 are involved in the development of varioliform gastritis. Keywords:Differentially expressed proteins, Varioliform gastritis, Proteomic study,Helicobacter pylori == INTRODUCTION == Varioliform gastritis is currently recognized as a special kind of chronic gastritis characterized by nodules, thickened fugal folds and erosions. These features appear to be unusual and different from those seen in chronic Telatinib (BAY 57-9352) gastritis. The diagnosis can be easily made by endoscopic examination. But the morbidity of varioliform gastritis has increased quickly recently in China. Very little is known about the etiopathogeny, clinical significance and evolution of this disease. The molecular biological researches on varioliform gastritis are very limited and no proteomics research on this disease has been found up to date. So the molecular mechanism of this disease is still unclear. The role ofHelicobacter pylori (H. pylori)remains unknown. Although a close relationship between this gastritis and the bacteria was suggested to exist over the last few years, But noH. pyloriinfection was found in the gastric Telatinib (BAY 57-9352) mucosa of some patients Rabbit Polyclonal to RPS25 with varioliform gastritis. What is the reason? Gastric cancer is the second most common malignancy in the world. Each year, about 798 000 people are diagnosed as having gastric cancer (9.9% of total cancer cases) and 628 000 people die from the Telatinib (BAY 57-9352) disease (12.1% of cancer deaths)[1]. In eastern Asian countries including China, the morbidity and mortality of gastric cancer have ranked the first among all kinds of cancer and grown rapidly in the past two decades. Gastric carcinogenesis is not a well-known process, and the central paradigm for the initiation and development of gastric carcinoma is still not very clear. In 1960, Munoz Monteavaro et al[2] reported varioliform gastritis with in situ carcinomatous transformation. It was reported a case of ampullary carcinoma accompanied with gastroenteropathy due to diffuse varioliform gastritis. Similarly, Cappell et al[3] reported adenomatous transformation in a patient with varioliform gastritis who had serial gastroscopies. This report also suggests a possible association between varioliform gastritis and gastric neoplasia. Several other groups have reported similar findings and performed a more comprehensive analysis of relationship between varioliform gastritis and gastric cancer[4-6]. The elevations could persist and appear as sessile polyps after the erosions heal and symptoms relieved after treatment. Adenomatous transformation was reported in some patients with varioliform gastritis. These reports suggested a possible association between varioliform gastritis and gastric neoplasia. Although this disease was concluded as a kind of precursor disease of gastric cancer at Sydney Conference, the mechanism of carcinogenesis from varioliform gastritis was unknown. Gastric cancer might be effectively controlled if this premalignant lesion-varioliform gastritis-is detected and treated before invasion occurs. Therefore, it is crucial to elucidate the molecular mechanism underlying varioliform gastritis. Some current mechanistic models focus almost around the localized lesion orH. pyloriinfection, with much less attention paid to pathologic changes occurring in the normal-appearing mucosa withoutH. pyloriinfection from which such lesions emerge. The pattern of expressed proteins can reflect the information about the functional status and Telatinib (BAY 57-9352) health of the tissue. Recently, the development of new methods for protein analysis has led to the emergence of a new field of clinical proteomics, in which these techniques are harnessed to identify functional molecular or biomarkers of cancer and other diseases[7], but there is hardly any study around the differential expressions of proteins in varioliform gastritis and normal-appearing mucosa. In the present study, we used proteomic techniques to test the hypothesis that normal gastric mucosa from a patient with varioliform gastritis would exhibit different pattens of protein expression with the disordered mucosa from the same patient. By this approach, comparison of anatomically normal and disordered tissues against the same genetic background could be made. == MATERIALS AND METHODS == == Sample collection == Samples were taken from 17 patients with varioliform gastritis in the Second Affiliated Hospital of General Hospital of PLA (Table1). These patients were examined by13C urea breath test and the results were all unfavorable. The results of autoantibody detection were also unfavorable in these patients. The case ofH. pyloriinfection and auto-immune disease.